Kenji Yamakawa
Directeur Général chez SNBL Clinical Pharmacy Center, Inc.
Profil
Kenji Yamakawa is currently the Chief Executive Officer at SNBL Clinical Pharmacy Center, Inc. since 2004 and also the Director at SNBL USA Ltd.
since 2010.
He was previously the Director at Shin Nippon Biomedical Laboratories, Ltd.
from 2010 to 2014.
Postes actifs de Kenji Yamakawa
| Sociétés | Poste | Début |
|---|---|---|
| SNBL Clinical Pharmacy Center, Inc. | Directeur Général | 01/10/2010 |
SNBL USA Ltd.
 SNBL USA Ltd. Medical/Nursing ServicesHealth Services SNBL USA Ltd. provides general toxicology, acute radiation syndrome, apheresis, CNS drug delivery, immunohistochemistry, tissue cross reactivity and biological services. The company is headquartered in Everrett, WA. | Directeur/Membre du Conseil | 01/06/2012 |
Anciens postes connus de Kenji Yamakawa
| Sociétés | Poste | Fin |
|---|---|---|
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Commercial Services |
| Entreprise privées | 2 |
|---|---|
| SNBL Clinical Pharmacy Center, Inc. | |
SNBL USA Ltd.
SNBL USA Ltd. Medical/Nursing ServicesHealth Services SNBL USA Ltd. provides general toxicology, acute radiation syndrome, apheresis, CNS drug delivery, immunohistochemistry, tissue cross reactivity and biological services. The company is headquartered in Everrett, WA. | Health Services |
